Editas Medicine Congress Trades
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 1:53 PM ET
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Apr 10, 2023
Editas Medicine Congress trading summary
Members of Congress have disclosed 11 transactions in Editas Medicine (EDIT) stock, reported by 3 politicians. No EDIT trades were reported with a transaction date in the past 12 months. The most active traders are Rep. Donald S. Beyer, Jr. (8), Rep. Donna E. Shalala (2), Rep. Daniel S. Goldman (1).
The latest reported trade is a sale by Daniel S. Goldman dated Apr 10, 2023 and disclosed on May 19, 2023. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading EDIT
EDIT trades by members of Congress
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell EDIT. How Congress trading data works